Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.
Choueiri TK, Motzer RJ, Rini BI, Haanen J, Campbell MT, Venugopal B, Kollmannsberger C, Gravis-Mescam G, Uemura M, Lee JL, Grimm MO, Gurney H, Schmidinger M, Larkin J, Atkins MB, Pal SK, Wang J, Mariani M, Krishnaswami S, Cislo P, Chudnovsky A, Fowst C, Huang B, di Pietro A, Albiges L. Choueiri TK, et al. Among authors: grimm mo. Ann Oncol. 2020 Aug;31(8):1030-1039. doi: 10.1016/j.annonc.2020.04.010. Epub 2020 Apr 25. Ann Oncol. 2020. PMID: 32339648 Free PMC article. Clinical Trial.
Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101.
Tomita Y, Larkin J, Venugopal B, Haanen J, Kanayama H, Eto M, Grimm MO, Fujii Y, Umeyama Y, Huang B, Mariani M, di Pietro A, Choueiri TK. Tomita Y, et al. Among authors: grimm mo. ESMO Open. 2022 Oct;7(5):100564. doi: 10.1016/j.esmoop.2022.100564. Epub 2022 Aug 28. ESMO Open. 2022. PMID: 36037566 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 33157721
[Follow-up of renal cell carcinoma in a nonmetastatic stage].
Szabados B, Foller S, Schulz GB, Staehler M, Grimm MO, Stief CG, Casuscelli J. Szabados B, et al. Among authors: grimm mo. Urologe A. 2019 Jan;58(1):65-76. doi: 10.1007/s00120-018-0823-z. Urologe A. 2019. PMID: 30627750 German.
[Adverse events of immune checkpoint inhibitors].
Foller S, Oppel-Heuchel H, Fetter I, Winkler Y, Grimm MO. Foller S, et al. Among authors: grimm mo. Urologe A. 2017 Apr;56(4):486-491. doi: 10.1007/s00120-017-0342-3. Urologe A. 2017. PMID: 28246759 German.
284 results